Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health Ampatzoglou, Antonios Gruszecka-Kosowska, Agnieszka Malgorzata Torres Sánchez, Alfonso López Moreno, Ana Cerk, Klara Ortiz Sandoval, Pilar Monteoliva Sánchez, Mercedes Aguilera Gómez, Margarita one health gut microbiome xenobiotics Three areas of relevance to the gut microbiome in the context of One Health were explored; the incorporation of the microbiome in food safety risk assessment of xenobiotics; the identification and application of beneficial microbial components to various areas under One Health, and; specifically, in the context of antimicrobial resistance. Although challenging, focusing on the microbiota resilience, function and active components is critical for advancing the incorporation of microbiome data in the risk assessment of xenobiotics. Moreover, the human microbiota may be a promising source of beneficial components, with the potential to metabolize xenobiotics. These may have possible applications in several areas, e.g., in animals or plants for detoxification or in the environment for biodegradation. This approach would be of particular interest for antimicrobials, with the potential to ameliorate antimicrobial resistance development. Finally, the concept of resistance to xenobiotics in the context of the gut microbiome may deserve further investigation. 2024-11-21T12:34:19Z 2024-11-21T12:34:19Z 2022-05-04 journal article Ampatzoglou A, Gruszecka-Kosowska A, Torres-Sánchez A, López-Moreno A, Cerk K, Ortiz P, Monteoliva-Sánchez M and Aguilera M (2022) Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health. Front. Microbiol. 13:872583. doi: 10.3389/fmicb.2022.872583 https://hdl.handle.net/10481/97223 10.3389/fmicb.2022.872583 eng http://creativecommons.org/licenses/by/4.0/ open access Atribución 4.0 Internacional Frontiers Media